Search…

Yabao Pharmaceutical: Net profit in the first quarter of 2024 was 107 million yuan, a year-on-year decrease of 4.45%.

26/04/2025

Yabao Pharmaceutical announced that the revenue for the first quarter of 2024 was 615 million RMB, a year-on-year decrease of 20.32%; the net profit was 107 million RMB, a year-on-year decrease of 4.45%.

Latest

3 m ago

FTSE A50 futures continued to rise by 0.27% in the overnight session, closing at 13,221 points.

9 m ago

Nomura: Maintains the rating of Rivian Automotive (RIVN.US) and adjusts it from reduce to hold, with a target price adjustment from $11.00 to $10.00.

10 m ago

On Friday, the offshore Chinese yuan against the US dollar was reported at 7.2885 at the New York closing, up 15 points from Thursday's New York closing. The overall intraday trading range was between 7.2986 and 7.2816 yuan.

10 m ago

The Federal Reserve released a financial stability report, indicating risks related to asset valuation pressures.

10 m ago

Park Ntl (PRK.US): The first quarter financial report of 2025 achieved a revenue of 1.301 billion US dollars, compared to 1.218 billion US dollars in the previous period, with an expected value of 1.304 billion US dollars. Earnings per share were $2.57, compared to $2.15 in the previous period, with an expected value of $2.15.

See all latest

+852 - 60190728

gmteight@futurecultural.com

Customer Support

Commercial Services